Review Article
Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin’s Lymphomas
Table 2
Ongoing lenalidomide (L) monotherapy trials.
| | Name | Phase | Age | Histology | Drugs | Status |
| | NCT00875667 | II | >18 ys | Relapsed or refractory MCL | L | Ongoing and recruiting | | NCT00737529 | II | >18 ys | Relapsed or refractory MCL | L | Ongoing and recruiting | | NCT00179673 | II | >18 ys | Relapsed or refractory indolent NHL | L | Terminated |
|
|
L: lenalidomide.
|
